Pyrimethamine is a protozoan infection treatment drug. It’s frequently used as an antimalarial medication (for both treatment and prevention of malaria) as well as to treat Toxoplasma gondii infections, especially when coupled with the sulfonamide antibiotic sulfadiazine in HIV-positive patients. Owing to its resistance to several plasmodium species, pyrimethamine is usually combined with sulfonamide and folinic acid. Pyrimethamine has also been shown to suppress the expression of the superoxide dismutase 1 gene, which is linked to amyotrophic lateral sclerosis.
Get Free Sample link @ https://www.omrglobal.com/request-sample/pyrimethamine-market
Pyrimethamine Tablets USP, 25 mg, a therapeutic equivalent and first-wave generic version of Daraprim (pyrimethamine) Tablets, was launched by Dr. Reddys Laboratories and was authorized by the US Food and Drug Administration (USFDA) in March 2020. The USFDA has authorized this generic version of Daraprim (pyrimethamine) Tablets as the sole AB-rated generic version of Daraprim (pyrimethamine) Tablets.
full report of Pyrimethamine Market available @ https://www.omrglobal.com/industry-reports/pyrimethamine-market
- Market Coverage
- Market number available for – 2024-2030
- Base year- 2023
- Forecast period- 2024-2030
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
- , and others
Pyrimethamine Market Report
By Type
- Tablets
- Capsules
- Injectables
By Drug
- Daraprim
- Fansidar
By End-User vertical
- Hospitals and Clinics
- Laboratories
- Others
By Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East & Africa
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pyrimethamine-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
